These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9140310)

  • 1. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
    Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
    Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation and overexpression of the p53 tumor suppressor gene frequently occurs in uterine and ovarian sarcomas.
    Liu FS; Kohler MF; Marks JR; Bast RC; Boyd J; Berchuck A
    Obstet Gynecol; 1994 Jan; 83(1):118-24. PubMed ID: 8272291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene.
    Stratton MR; Moss S; Warren W; Patterson H; Clark J; Fisher C; Fletcher CD; Ball A; Thomas M; Gusterson BA
    Oncogene; 1990 Sep; 5(9):1297-301. PubMed ID: 2216456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
    Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
    Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of the p53 gene in postradiation sarcoma.
    Nakanishi H; Tomita Y; Myoui A; Yoshikawa H; Sakai K; Kato Y; Ochi T; Aozasa K
    Lab Invest; 1998 Jun; 78(6):727-33. PubMed ID: 9645763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of p53 exon 4 mutations in soft tissue sarcoma.
    Das P; Kotilingam D; Korchin B; Liu J; Yu D; Lazar AJ; Pollock RE; Lev D
    Cancer; 2007 Jun; 109(11):2323-33. PubMed ID: 17429838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 abnormalities in different subtypes of human sarcomas.
    Andreassen A; Oyjord T; Hovig E; Holm R; Flørenes VA; Nesland JM; Myklebost O; Høie J; Bruland OS; Børresen AL
    Cancer Res; 1993 Feb; 53(3):468-71. PubMed ID: 8425179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of germline and tumor mutations of p53 gene in familial occurrence of soft tissue sarcomas.
    Kudawara I; Matsumine A; Ohzono K
    J Surg Oncol; 2007 Mar; 95(4):347-50. PubMed ID: 17192950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between p53 gene mutation and protein expression in 30 cases of human lung cancer].
    Zhang J; Zheng J; Fang W
    Zhonghua Yi Xue Za Zhi; 1998 Nov; 78(11):846-9. PubMed ID: 11038779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas.
    Meye A; Würl P; Hinze R; Berger D; Bache M; Schmidt H; Rath FW; Taubert H
    J Pathol; 1998 Jan; 184(1):14-7. PubMed ID: 9582521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients.
    Yoo J; Robinson RA
    Cancer; 1999 Jul; 86(1):58-63. PubMed ID: 10391564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation spectrum of the p53 gene in bone and soft tissue sarcomas.
    Toguchida J; Yamaguchi T; Ritchie B; Beauchamp RL; Dayton SH; Herrera GE; Yamamuro T; Kotoura Y; Sasaki MS; Little JB
    Cancer Res; 1992 Nov; 52(22):6194-9. PubMed ID: 1423262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infrequent p53 gene mutations and lack of p53 protein expression in clear cell sarcoma of the kidney: immunohistochemical study and mutation analysis of p53 in renal tumors of unfavorable prognosis.
    Hsueh C; Wang H; Gonzalez-Crussi F; Lin JN; Hung IJ; Yang CP; Jiang TH
    Mod Pathol; 2002 Jun; 15(6):606-10. PubMed ID: 12065773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia.
    Creager AJ; Cohen JA; Geradts J
    Cancer Detect Prev; 2001; 25(2):123-31. PubMed ID: 11341347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas.
    Oda H; Nakatsuru Y; Ishikawa T
    Cancer Res; 1995 Feb; 55(3):658-62. PubMed ID: 7834636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas.
    Brachman DG; Hallahan DE; Beckett MA; Yandell DW; Weichselbaum RR
    Cancer Res; 1991 Dec; 51(23 Pt 1):6393-6. PubMed ID: 1933904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas.
    Bohle RM; Brettreich S; Repp R; Borkhardt A; Kosmehl H; Altmannsberger HM
    Am J Pathol; 1996 Mar; 148(3):731-8. PubMed ID: 8774129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of p53 and p110RB tumor suppressor gene expression in human soft tissue tumors: correlations with cell proliferation and tumor grade.
    Wang J; Coltrera MD; Gown AM
    Mod Pathol; 1995 Oct; 8(8):837-42. PubMed ID: 8552572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H-ras-1 point mutations in soft tissue sarcomas.
    Wilke W; Maillet M; Robinson R
    Mod Pathol; 1993 Mar; 6(2):129-32. PubMed ID: 8483882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.